AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was $6.54, up 45.3% from the year before. Over ten years it grew 11.4% a year on average. The highest annual figure on record is $6.54 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.54 | +45.3% |
| FY2024 | Dec 31, 2024 | $4.50 | +18.1% |
| FY2023 | Dec 31, 2023 | $3.81 | +80.6% |
| FY2022 | Dec 31, 2022 | $2.11 | +2537.5% |
| FY2021 | Dec 31, 2021 | $0.08 | -96.7% |
| FY2020 | Dec 31, 2020 | $2.44 | +136.9% |
| FY2019 | Dec 31, 2019 | $1.03 | -39.4% |
| FY2018 | Dec 31, 2018 | $1.70 | -28.3% |
| FY2017 | Dec 31, 2017 | $2.37 | -14.1% |
| FY2016 | Dec 31, 2016 | $2.76 | +23.8% |
| FY2015 | Dec 31, 2015 | $2.23 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.61 | +600.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.57 | +273.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.24 | +113.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.17 | +1070.0% |
| Q2 FY2022 | Jun 30, 2022 | $0.23 | -14.8% |
| Q2 FY2021 | Jun 30, 2021 | $0.42 | +10.5% |
| Q2 FY2020 | Jun 30, 2020 | $0.58 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.10 | – |
| Q2 FY2018 | Jun 30, 2018 | $0.27 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.38 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?